Anti-Hepatocellular and anti-lung Carcinoma Effect of the Selenium Nanoparticles Myco-Synthesized by Penicillium citrnium: An in Vitro Study. | ||
| Egyptian Journal of Chemistry | ||
| Volume 67, Issue 12, December 2024, Pages 157-166 PDF (770.91 K) | ||
| Document Type: Review Articles | ||
| DOI: 10.21608/ejchem.2024.277342.9464 | ||
| Authors | ||
| Marwa K. Aly* 1; A. F. El-Baz2; Abdel Hady A. Abdel Wahab3; Amal A. I. Mekawey4; Ebtehag A.E. Sakr5; Mehreshan T. El-mokadem5 | ||
| 1Central Laboratory,Ministry of Environment, Cairo 11728, Egypt | ||
| 2Department of Industrial Biotechnology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City 32897, Egypt. | ||
| 3Cancer Biology Department, National Cancer Institute, Cairo University, Cairo 11796, Egypt. | ||
| 4The regional center of mycology and biotechnology, Al Azhar University, Cairo 11787, Egypt. | ||
| 5Botany Department, Faculty of Women for Arts, Science and Education, Ain Shams University, Cairo 11757, Egypt. | ||
| Abstract | ||
| In the current study, biogenic selenium nanoparticles (Se-NPs) were extracellularly synthesized by Penicillium citrnium. Se-NPs were structurally and morphologically characterized by using analytical techniques such as: X-ray diffraction (XRD), UV-Vis spectroscopy, Fourier Transform Infrared Spectroscopy (FTIR) and transmission electron microscopy (TEM). Maximum UV absorbance was obtained at 255 nm. and the TEM showed 15–40 nm-sized homogeneous spherical Se-NPs. Anticancer potential of the Se-NPs was evaluated against lung cancer (A-459), hepatocellular carcinoma (HepG2), and its cytotoxicity against normal fibroblast cells (WI-38). The Se-NPs have a significant cytotoxic effect (IC50) of 100.2 ± 3.28 µg/mL against HepG2 cells and IC50 of 142.5 ± 6.91 µg/mL against A-549 cells, whereas it has IC50 of 219.75 ± 10.93 µg/mL against Wl-38 cells. In comparison to the untreated HepG2 cells, the treated cells showed a 1.8 and 1.7-fold increase in superoxide dismutase enzyme (SOD) and glutathione (GSH) content, respectively, with a 0.6 fold drop in catalase (CAT) level. The cell apoptosis rates were also assesed using the Annexin V-FITC staining test. In the treated cells, the rates of necrosis, late apoptosis, and early apoptosis were all markedly elevated. The caspase-3 enzyme level of the treated cells was 2.2 folds higher than that of the untreated cells. Flow cytometer showed an arrest in G2/M phase in comparison to untreated cells after treatment of HepG2 with Se-NP. In conclusion, the biogenic Se-NPs exhibited anticancer activity against HepG2 hepatocellular carcinoma cells through enhanced antioxidant production, apoptosis, and cell cycle arrest pathways. | ||
| Keywords | ||
| Selenium Nanoparticles; Hepatocellular carcinoma; antioxidant enzymes; Apoptosis; Penicillium citrnium | ||
|
Statistics Article View: 423 PDF Download: 441 |
||
